Linkedin

Home
Startup Insight
Stories
Articles
Features

Loading…

Home Tags Frazier Life Sciences

Frazier Life Sciences

Scorpion Therapeutics, Inc. (“Scorpion”), a pioneering clinical-stage oncology company dedicated to transforming the lives of cancer patients by redefining the frontier of precision oncology, today announced the closing of a $150 million Series C financing.

[Funding News] Scorpion Therapeutics Raises $150 Million Series C Funding

Team SR - July 16, 2024

ABOUT US

Startup Rise - America is rapidly growing business media platform for entrepreneurs and startups to cover and publish their journeys through Video Talks, Interviews, Articles and News.

Contact us: contact@startuprise.io

FOLLOW US

© Copyright startuprise 2024 All Rights Reserved.

Exit mobile version